Pepper-Based patch may ease Post-Surgery nerve pain better than pills
NCT ID NCT03794388
First seen May 06, 2026 · Last updated Jun 19, 2026 · Updated 9 times
Summary
This study tested whether a capsaicin skin patch (made from chili peppers) works better than oral pregabalin for treating nerve pain that starts soon after breast cancer surgery. 140 women who had surgery for breast cancer and developed nerve pain within 2 months were enrolled. The goal was to see if early treatment with the patch could prevent long-term chronic pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER PATIENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU NICE
Nice, 06003, France
-
Centre Leon Berard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Ch Valenciennes
Valenciennes, 53322, France
-
Chd Vendee
La Roche-sur-Yon, 85025, France
-
Chu Grenoble
Grenoble, 38700, France
-
Hopital Saint Vincent de Paul
Lille, 59020, France
-
Institut Curie
Saint-Cloud, 92210, France
-
Institut Jean Godinot
Reims, 51100, France
-
Institut de Cancerologie de L'Ouest
Angers, 49000, France
-
Iuct Oncopole
Toulouse, 31052, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.